Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Total Long Term Debt: 2009-2010

Historic Total Long Term Debt for Cumberland Pharmaceuticals (CPIX) over the last 2 years, with Dec 2010 value amounting to $313,575.

  • Cumberland Pharmaceuticals' Total Long Term Debt rose 161.37% to $313,575 in Q4 2010 from the same period last year, while for Dec 2010 it was $313,575, marking a year-over-year increase of 161.37%. This contributed to the annual value of $313,575 for FY2010, which is 161.37% up from last year.
  • Per Cumberland Pharmaceuticals' latest filing, its Total Long Term Debt stood at $313,575 for Q4 2010, which was up 396.75% from -$105,668 recorded in Q3 2010.
  • Cumberland Pharmaceuticals' 5-year Total Long Term Debt high stood at $582,254 for Q2 2009, and its period low was -$510,942 during Q4 2009.
  • Moreover, its 2-year median value for Total Long Term Debt was -$105,668 (2010), whereas its average is -$70,509.
  • Data for Cumberland Pharmaceuticals' Total Long Term Debt shows a peak YoY soared of 161.37% (in 2010) over the last 5 years.
  • Cumberland Pharmaceuticals' Total Long Term Debt (Quarterly) stood at -$510,942 in 2009, then soared by 161.37% to $313,575 in 2010.
  • Its Total Long Term Debt was $313,575 in Q4 2010, compared to -$105,668 in Q3 2010 and $88,739 in Q1 2010.